When co-activated with GLP-1R, NPY2R induces greater weight loss, improves insulin sensitivity and restores beta cell function in mouse models of obesity/type 2 diabetes [21–23]. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.